Related Experiment Video
Updated: Jan 13, 2026

08:15
Polymeric Microneedle Array Fabrication by Photolithography
Published on: November 17, 2015
12.8K
Integrating Polymeric 3D-Printed Microneedles with Wearable Devices: Toward Smart and Personalized Healthcare
1Department of Mechanical Engineering, University of Victoria, Victoria, BC V8P 5C2, Canada.
Polymers
|January 10, 2026
Summary
Wearable microneedle arrays (MNAs) are evolving from passive tracking to active, closed-loop systems for personalized drug delivery. Advances in 3D printing and AI promise "wearable clinics" for real-time monitoring and therapy.
Area of Science:
- Biomedical Engineering
- Materials Science
- Wearable Technology
Background:
- Wearable healthcare is transitioning from passive monitoring to active, closed-loop therapeutic systems.
- Polymeric microneedle arrays (MNAs) are key components in this shift, enabling minimally invasive interstitial fluid access and localized drug delivery.
Purpose of the Study:
- This review surveys the design, materials, and manufacturing of skin-conformal MNA wearables.
- It explores the potential of integrated systems for personalized, real-time monitoring and therapy.
- The review aims to identify challenges and future directions for clinical translation.
Main Methods:
- Review of current literature on 3D-printed microneedle arrays (MNAs).
- Analysis of design principles, material selection, and manufacturing techniques.
- Examination of enabling technologies like soft electronics, wireless modules, and AI-driven control.
Main Results:
- A clear transition from proof-of-concept MNA devices to integrated, wearable, closed-loop therapeutic platforms is observed.
- Converging advances in multimaterial printing, nano/biofunctional coatings, and AI are paving the way for
- wearable clinics
- .
Conclusions:
- Key challenges for clinical translation include scalable manufacturing, drug dose limitations, long-term stability, and regulatory hurdles.
- Addressing gaps in hollow MNA architectures, system integration, and evaluation protocols will accelerate adoption.
- Realization of closed-loop systems is constrained by power consumption, data latency, and the need for clinical validation.

